Tamoxifen by Hilma Biocar

$$C_{26}H_{29}NO$$

Mechanism of Action

Tamoxifen is a non-steroidal agent that exerts its effect by binding to estrogen receptors in various tissues.

In Breast Tissue: It acts as an antagonist, blocking estrogen from attaching to receptors. This inhibits the growth of estrogen-sensitive tumors.
In Other Tissues (e.g., Bone/Liver): It can act as a partial agonist, mimicking estrogen’s beneficial effects, such as maintaining bone density and improving lipid profiles.

Common Applications

Medical Treatment: FDA-approved for the treatment and prevention of hormone-receptor-positive breast cancer in both women and men.
Hormonal Regulation: Used to address gynecomastia (enlargement of male breast tissue).
Post-Cycle Recovery: In specific performance contexts, it is used to stimulate the pituitary gland to release LH (luteinizing hormone) and FSH (follicle-stimulating hormone), which aids in the restoration of natural testosterone production.

Standard Dosing Guidelines

For Breast Cancer: Typically 20 mg to 40 mg daily. Doses above 20 mg are usually split into morning and evening administrations.
For Hormonal Recovery: Usually 20 mg daily for a duration of 4 to 6 weeks, depending on the specific recovery protocol.

Safety & Precautions

Common Side Effects: Hot flashes, nausea, headache, and leg cramps.
Serious Risks: Increased risk of blood clots (DVT/PE), stroke, and in long-term female users, uterine cancer.
Interactions: Should not be used alongside certain antidepressants (like Fluoxetine or Paroxetine) which can inhibit the enzyme (CYP2D6) required to convert Tamoxifen into its active form.